PFO
SYRS

Pathstone Family Office’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Pathstone Family Office’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-43,826
Closed -$282K – 1584
2022
Q3 		$282K Buy
+43,826
New +$282K ﹤0.01% 1235